Kostas Drosopoulos Joins the Team Full Time

January 8, 2024

Our Director of Business Development

Director of Business Development

Dr Drosopoulos is a seasoned professional with a strong background in drug discovery and target ID. With extensive experience in identifying and validating drug targets, Kostas has successfully worked with cross-functional teams and managed partnerships with leading pharmaceutical companies. Prior to joining Chromatin Bioscience in 2024, he worked as a Staff Scientist at the Institute of Cancer Research, where he contributed to multiple projects in cancer therapeutics. Now, as Director of Business Development at Chromatin Bioscience, Kostas leverages his scientific expertise and industry insights to foster strategic collaborations and and drive the application of Chromatin Bioscience’s innovative synthetic promoters, designed to elevate the safety, efficacy, and bioprocessing efficiency of our partners' therapeutic developments.

By Michael Roberts April 14, 2025
EDINBURGH, Scotland, April 14, 2025
By Michael Roberts April 13, 2025
June 16-19, 2024 | Boston, MA, USA
By Michael Roberts April 12, 2025
May 13-17, 2025 | New Orleans, LA, USA
By Michael Roberts March 11, 2025
March 18-19, 2025 | London, UK
By Michael Roberts February 20, 2025
EDINBURGH, Scotland, Feb. 20, 2025
By Michael Roberts January 20, 2025
We are thrilled to be working with Johnson & Johnson, a leader in global healthcare innovation.
By Michael Roberts January 12, 2025
January 29-30, 2025 | London, UK
By Michael Roberts January 3, 2025
January 20-23, 2025 | Dallas, Texas
By Michael Roberts October 22, 2024
Oct 22-25, 2024 | Rome, Italy
More Posts